Cerebral hemorrhage and cerebral infarction
Conditions
Interventions
Control group:General rehabilitation therapy
Intervention group 1:General rehabilitation therapy+repetitive transcranial magnetic stimulation(rTMS).
Intervention group 2:General rehabilitation therapy+repetitive transcranial magnetic stimulation(rTMS)+mirror therapy.
Sponsors
Nanchong Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.All met the diagnostic criteria of China Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage 2019 and China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018, and confirmed stroke disease by craniocerebral CT or MRI; 2.The patient's vital signs were stable, with no serious complications of lung, liver, heart, kidney and other organs; 3.The first onset, and one side of the limb paralysis, the course of the disease is more than two weeks; 4.Patients with good cognitive function [simple cognitive status checklist (MMSE)> 23 points], good mental condition, can cooperate with evaluation and treatment; 5.The patient and their family members were informed about this study, agreed to participate in this study, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Wearing pacemakers, metal implants and other metal implants in the skull, or patients with skull defects, epilepsy, pregnancy, lactation, or women of childbearing age who have not taken reliable contraceptive measures; 2.Severe systemic diseases cannot participate in the study: patients with severe respiratory, cardiac, liver, kidney, endocrine and hematopoietic diseases, such as congestive heart failure, arrhythmia, hypertension without control; 3.The limbs have obvious deformity or other diseases affecting the movement of the lower limbs, such as: serious infection of the lower limbs, contracture, joint surgery, amputation, fracture, rheumatism or rheumatoid arthritis; 4.Severe speech, vision, hearing and other disorders (such as deaf people) or mental disorders affecting the examination and treatment; 5.Uncontrolled seizures or epilepsy; 6.Severe cognitive dysfunction; 7.Patients who have recently participated in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer lower extremity function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ability to perform activities of daily living; | — |
Countries
China
Contacts
Public ContactLi Huifeng
Nanchong Central Hospital
Outcome results
None listed